Mutational analysis of human tumor necrosis factor-α

被引:3
作者
Shin, HC [1 ]
Cho, KH
机构
[1] Soongsil Univ, Dept Bioinformat & Life Sci, Seoul 156743, South Korea
[2] Soongsil Univ, Comp Aided Mol Design Res Ctr, Seoul 156743, South Korea
关键词
cytotoxicity; muteins; receptor binding; structure-function relationship; tumor necrosis factor-alpha;
D O I
10.1007/s10529-004-6937-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To understand the structure-function relationship of human tumor necrosis factor-alpha ( TNF-alpha), mutational analysis was carried out on the lower regions ( regions 1-6) of the molecule. The muteins were prepared as a soluble form by using a chaperonin co-expression system and the cytotoxic activities of the purified muteins were evaluated on TNF-sensitive murine. fibrosarcoma L929 cells. Three regions ( regions 1, 2 & 4) were found where mutations significantly influenced the bioactivity. In region 1 ( residues 1-10), the number of deleted residues and the positioning of positive charges are important to achieve a maximum activity and in region 4 ( residues 84-88), introduction of charged residues in one of the positions 86-88 significantly increased the cytotoxic activity. On the other hand, any mutation introduced in region 2 ( residues 37-41) had a deleterious effect. The present study provides a structural basis for the design of highly potent TNF-alpha as a therapeutic agent.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 23 条
[1]   Selective targeted delivery of TNFα to tumor blood vessels [J].
Borsi, L ;
Balza, E ;
Carnemolla, B ;
Sassi, F ;
Castellani, P ;
Berndt, A ;
Kosmehl, H ;
Bir, A ;
Siri, A ;
Orecchia, P ;
Grassi, J ;
Ned, D ;
Zardi, L .
BLOOD, 2003, 102 (13) :4384-4392
[2]   2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity [J].
Cha, SS ;
Kim, MS ;
Choi, YH ;
Sung, BJ ;
Shin, NK ;
Shin, HC ;
Sung, YC ;
Oh, BH .
IMMUNITY, 1999, 11 (02) :253-261
[3]  
Corti Angelo, 2004, Methods Mol Med, V98, P247
[4]   A FAMILY OF LIGANDS FOR THE TNF RECEPTOR SUPERFAMILY [J].
COSMAN, D .
STEM CELLS, 1994, 12 (05) :440-455
[5]  
CREASEY AA, 1987, CANCER RES, V47, P145
[6]  
ECK MJ, 1992, J BIOL CHEM, V267, P2119
[7]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P14497
[8]   CHARACTERIZATION OF BINDING AND BIOLOGICAL EFFECTS OF MONOCLONAL-ANTIBODIES AGAINST A HUMAN TUMOR NECROSIS FACTOR RECEPTOR [J].
ESPEVIK, T ;
BROCKHAUS, M ;
LOETSCHER, H ;
NONSTAD, U ;
SHALABY, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) :415-426
[9]   TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL [J].
FIERS, W .
FEBS LETTERS, 1991, 285 (02) :199-212
[10]  
GATANAGA T, 1989, J BIOL RESP MODIF, V8, P278